Jeff Yass’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-368
Closed -$79K 11073
2019
Q1
$79K Sell
368
-72
-16% -$29K ﹤0.01% 8337
2018
Q4
$152K Sell
440
-104
-19% -$80.8K ﹤0.01% 7971
2018
Q3
$631K Buy
544
+478
+724% +$440K ﹤0.01% 6109
2018
Q2
$56K Sell
66
-74
-53% -$61.5K ﹤0.01% 9243
2018
Q1
$164K Buy
140
+27
+24% +$29.8K ﹤0.01% 8471
2017
Q4
$104K Sell
113
-267
-70% -$247K ﹤0.01% 8674
2017
Q3
$417K Sell
380
-19
-5% -$21.6K ﹤0.01% 6833
2017
Q2
$459K Sell
399
-65
-14% -$79.1K ﹤0.01% 6812
2017
Q1
$535K Buy
464
+286
+161% +$276K ﹤0.01% 6359
2016
Q4
$188K Buy
178
+81
+84% +$36.8K ﹤0.01% 8692
2016
Q3
$39K Buy
97
+13
+15% +$5.3K ﹤0.01% 8187
2016
Q2
$35K Buy
84
+23
+38% +$11.3K ﹤0.01% 8302
2016
Q1
$26K Sell
61
-281
-82% -$109K ﹤0.01% 8786
2015
Q4
$197K Sell
342
-137
-29% -$96K ﹤0.01% 8437
2015
Q3
$426K Buy
479
+36
+8% +$32.8K ﹤0.01% 7413
2015
Q2
$456K Sell
443
-391
-47% -$458K ﹤0.01% 7805
2015
Q1
$1.19M Buy
834
+260
+45% +$330K ﹤0.01% 5397
2014
Q4
$803K Sell
574
-54
-9% -$78K ﹤0.01% 6298
2014
Q3
$768K Buy
628
+551
+716% +$792K ﹤0.01% 6441
2014
Q2
$139K Buy
+77
New +$103K ﹤0.01% 9284

Other funds holding HSTO

Jeff Yass's HSTO Position: Q2 2023 in Review

Jeff Yass sold out of Histogen Inc. Common Stock (HSTO) in Q2 2023, closing a stake of 15,487 shares — an estimated $18.7K sold.

Jeff Yass first reported a position in HSTO in Q3 2014 and held it in 19 quarters. The position peaked at $1.14M in Q3 2018. 13 funds tracked by Wall St. Rank hold HSTO as of Q2 2023.

  • Jeff Yass reported no remaining Histogen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Jeff Yass sold 15,487 Histogen Inc. Common Stock shares in Q2 2023, an estimated $18.7K.
  • Jeff Yass first reported a position in Histogen Inc. Common Stock in Q3 2014 and held it in 19 quarters.
  • Jeff Yass's Histogen Inc. Common Stock position peaked at $1.14M in Q3 2018.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.